Feb 16, 2021 8:10am EST Sonnet BioTherapeutics Provides Fiscal Year 2021 First Quarter Business and Earnings Update
Feb 3, 2021 6:30am EST Sonnet BioTherapeutics Announces Abstract Accepted for Presentation at AACR 2021 Annual Meeting